TABLE 1.
Case series demographic information
| Patients (n) | 10 |
| Affected parotid glands (n) | 13 |
| Age, mean years [range] | 52 [27‐68] |
| Sex (M:F) | 2:8 |
| Autoimmune disorder (n, %) | 5 (50%) |
| Pre‐treatment COSS | |
| Mean score [range] | 47 [28.5‐75.5] |
| 2‐3 months post‐Botox COSS | |
| Mean score [range] | 25.9 [18.5‐53]* |
| 9‐12 months post‐Botox COSS | |
| Mean score [range] | 26.1 [18.5‐51.5] |
| Presenting symptom (n, % of glands) | |
| Swelling only | 5 (38%) |
| Swelling and pain | 7 (54%) |
| Itching | 1 (8%) |
Abbreviations: COSS, Chronic Obstructive Sialadenitis Symptoms Score; M:F, male to female ratio; n, number.
*P < .05 denotes significant difference from baseline.